Hbk Investments L P Seagen Inc. Transaction History

Hbk Investments L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	N/A	-1,000,000 Closed	0 $0
Q2 2024 Aug 14, 2024	SELL	N/A	-400,000 Closed	0 $0
Q3 2023 Nov 14, 2024	BUY	$191.51 - $216.16 $192 Million - $216 Million	1,000,000 New	1,000,000 $212 Million
Q2 2023 Aug 14, 2024	BUY	$187.64 - $206.25 $75.1 Million - $82.5 Million	400,000 New	400,000 $77 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.